Expert NetworkExpert InterviewAZN

Slingshot members are talking to an expert! The topic is:

Digging into the results from the P3 ALPHA trial of AstraZeneca's danicopan (ALXN2040) in patients with paroxysmal nocturnal hemoglobinuria who experience extravascular hemolysis

Executed on:Jul 11, 2023 5:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Ochsner Medical Center
  • Board Certified Hematologist/Oncologist  at Oschner Medical Center with over 13 years of experience.
  • Treats 8-10 patients with PNH.
  • Research interest in multiple myeloma, acute lymphoblastic leukemia, and acute myeloid leukemia; Clinical specializes in cell therapy and stem cell transplant.

Interview Goal

On this call we will be digging in to AstraZeneca's danicopan, a first-in-class oral Factor D inhibitor and the results from the Phase III ALPHA trial in patients with paroxysmal nocturnal haemoglobinuria and extravascular hemolysis.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.